BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee D, Minko T. Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier. Pharmaceutics 2021;13:2049. [PMID: 34959331 DOI: 10.3390/pharmaceutics13122049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Taratula O, Taratula OR. Novel Nanoparticle-Based Treatment and Imaging Modalities. Pharmaceutics 2023;15. [PMID: 36678873 DOI: 10.3390/pharmaceutics15010244] [Reference Citation Analysis]
2 Prentice RN, Rizwan SB. Translational Considerations in the Development of Intranasal Treatments for Epilepsy. Pharmaceutics 2023;15. [PMID: 36678862 DOI: 10.3390/pharmaceutics15010233] [Reference Citation Analysis]
3 Duong VA, Nguyen TT, Maeng HJ. Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery. Pharmaceutics 2023;15. [PMID: 36678838 DOI: 10.3390/pharmaceutics15010207] [Reference Citation Analysis]
4 Pineda E, Domenech M, Hernández A, Comas S, Balaña C. Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects. OTT 2023;Volume 16:71-86. [DOI: 10.2147/ott.s366371] [Reference Citation Analysis]
5 Vasilieva EA, Kuznetsova DA, Valeeva FG, Kuznetsov DM, Zakharov AV, Amerhanova SK, Voloshina AD, Zueva IV, Petrov KA, Zakharova LY. Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes. Pharmaceutics 2022;14. [PMID: 36559339 DOI: 10.3390/pharmaceutics14122846] [Reference Citation Analysis]
6 Pawar B, Vasdev N, Gupta T, Mhatre M, More A, Anup N, Tekade RK. Current Update on Transcellular Brain Drug Delivery. Pharmaceutics 2022;14. [PMID: 36559214 DOI: 10.3390/pharmaceutics14122719] [Reference Citation Analysis]
7 Formica ML, Real DA, Picchio ML, Catlin E, Donnelly RF, Paredes AJ. On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles. Applied Materials Today 2022;29:101631. [DOI: 10.1016/j.apmt.2022.101631] [Reference Citation Analysis]
8 D’souza A, Nozohouri S, Bleier BS, Amiji MM. CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood–Brain Barrier and Towards Specific Cellular Targeting. Pharm Res 2022. [DOI: 10.1007/s11095-022-03433-5] [Reference Citation Analysis]
9 Gakis G, Krikas A, Neofytou P, Tran L, Charitidis C. Modelling the biodistribution of inhaled gold nanoparticles in rats with interspecies extrapolation to humans. Toxicology and Applied Pharmacology 2022. [DOI: 10.1016/j.taap.2022.116322] [Reference Citation Analysis]
10 Saha P, Kathuria H, Pandey MM. Nose-to-brain delivery of rotigotine redispersible nanosuspension: In vitro and in vivo characterization. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104049] [Reference Citation Analysis]
11 Gabold B, Adams F, Brameyer S, Jung K, Ried CL, Merdan T, Merkel OM. Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins. Drug Deliv Transl Res 2022. [PMID: 36207657 DOI: 10.1007/s13346-022-01245-z] [Reference Citation Analysis]
12 Rajput A, Pingale P, Dhapte-pawar V. Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects. Front Pharmacol 2022;13:979682. [DOI: 10.3389/fphar.2022.979682] [Reference Citation Analysis]
13 Gong Y, Guo Y, Jiang Y, Xing Z, Zhang H, Wang H, Gong Y. Intracerebroventricular injection of ghrelin receptor antagonist alleviated NAFLD via improving hypothalamic insulin resistance. Iran J Basic Med Sci 2022;25:1117-22. [PMID: 36246070 DOI: 10.22038/IJBMS.2022.64792.14272] [Reference Citation Analysis]
14 Pandya T, Dharamsi A. Preparation and Optimization of Leuprolide Acetate Nanoparticles Using Response Surface Methodology: In Vitro and Ex Vivo Evaluation. ASSAY and Drug Development Technologies 2022;20:237-249. [DOI: 10.1089/adt.2022.051] [Reference Citation Analysis]
15 Reagen S, Zhao JX. Analysis of Nanomaterials on Biological and Environmental Systems and New Analytical Methods for Improved Detection. IJMS 2022;23:6331. [DOI: 10.3390/ijms23116331] [Reference Citation Analysis]
16 Javed S, Mangla B, Almoshari Y, Sultan MH, Ahsan W. Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnology Reviews 2021;11:1744-77. [DOI: 10.1515/ntrev-2022-0109] [Reference Citation Analysis]